It is also tempting to speculate, based on the postulated role of both PLK1 and TTK in DNA damage response (see (59, 60), and references therein) that persistent DNA damage after combined treatment with carboplatin and BAL0891 might contribute to increased tumor cell death. This evidence concerns the gene PLK1 and neoplasm.